These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 35532243

  • 21. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B, Ye D, Yang H, Song J, Sun X, Mao Y, He Z.
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [Abstract] [Full Text] [Related]

  • 22. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
    Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L.
    BMC Microbiol; 2011 Jan 10; 11():7. PubMed ID: 21219646
    [Abstract] [Full Text] [Related]

  • 23. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
    Carstens A, Dicksved J, Nelson R, Lindqvist M, Andreasson A, Bohr J, Tysk C, Talley NJ, Agréus L, Engstrand L, Halfvarson J.
    Clin Transl Gastroenterol; 2019 Jul 10; 10(7):e00065. PubMed ID: 31343467
    [Abstract] [Full Text] [Related]

  • 24. Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Basson AR, Gomez-Nguyen A, Menghini P, Buttó LF, Di Martino L, Aladyshkina N, Osme A, LaSalla A, Fischer D, Ezeji JC, Erkkila HL, Brennan CJ, Lam M, Rodriguez-Palacios A, Cominelli F.
    Inflamm Bowel Dis; 2020 Feb 11; 26(3):347-359. PubMed ID: 31750921
    [Abstract] [Full Text] [Related]

  • 25. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS.
    Indian J Med Res; 2015 Jul 11; 142(1):23-32. PubMed ID: 26261163
    [Abstract] [Full Text] [Related]

  • 26. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J, Brislawn CJ, Lamendella R, Vázquez-Baeza Y, Walters WA, Bramer LM, D'Amato M, Bonfiglio F, McDonald D, Gonzalez A, McClure EE, Dunklebarger MF, Knight R, Jansson JK.
    Nat Microbiol; 2017 Feb 13; 2():17004. PubMed ID: 28191884
    [Abstract] [Full Text] [Related]

  • 27. Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.
    Thipart K, Gruneck L, Phunikhom K, Sharpton TJ, Sattayasai J, Popluechai S.
    Int Microbiol; 2023 May 13; 26(2):423-434. PubMed ID: 36484910
    [Abstract] [Full Text] [Related]

  • 28. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
    Maldonado-Arriaga B, Sandoval-Jiménez S, Rodríguez-Silverio J, Lizeth Alcaráz-Estrada S, Cortés-Espinosa T, Pérez-Cabeza de Vaca R, Licona-Cassani C, Gámez-Valdez JS, Shaw J, Mondragón-Terán P, Hernández-Cortez C, Suárez-Cuenca JA, Castro-Escarpulli G.
    Microbiologyopen; 2021 Mar 13; 10(2):e1181. PubMed ID: 33970546
    [Abstract] [Full Text] [Related]

  • 29. Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis.
    Jalanka J, Cheng J, Hiippala K, Ritari J, Salojärvi J, Ruuska T, Kalliomäki M, Satokari R.
    Int J Mol Sci; 2020 Aug 22; 21(17):. PubMed ID: 32842596
    [Abstract] [Full Text] [Related]

  • 30. Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn's disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets.
    Khorsand B, Asadzadeh Aghdaei H, Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B, Houri H.
    Front Cell Infect Microbiol; 2022 Aug 22; 12():1015890. PubMed ID: 36268225
    [Abstract] [Full Text] [Related]

  • 31. A Novel Microbial Dysbiosis Index and Intestinal Microbiota-Associated Markers as Tools of Precision Medicine in Inflammatory Bowel Disease Paediatric Patients.
    Toto F, Marangelo C, Scanu M, De Angelis P, Isoldi S, Abreu MT, Cucchiara S, Stronati L, Del Chierico F, Putignani L.
    Int J Mol Sci; 2024 Sep 05; 25(17):. PubMed ID: 39273567
    [Abstract] [Full Text] [Related]

  • 32. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients.
    Scanu M, Toto F, Petito V, Masi L, Fidaleo M, Puca P, Baldelli V, Reddel S, Vernocchi P, Pani G, Putignani L, Scaldaferri F, Del Chierico F.
    Front Cell Infect Microbiol; 2024 Sep 05; 14():1366192. PubMed ID: 38779566
    [Abstract] [Full Text] [Related]

  • 33. Gut microbiota signatures in inflammatory bowel disease.
    Vestergaard MV, Allin KH, Eriksen C, Zakerska-Banaszak O, Arasaradnam RP, Alam MT, Kristiansen K, Brix S, Jess T.
    United European Gastroenterol J; 2024 Feb 05; 12(1):22-33. PubMed ID: 38041519
    [Abstract] [Full Text] [Related]

  • 34. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
    Cook L, Lisko DJ, Wong MQ, Garcia RV, Himmel ME, Seidman EG, Bressler B, Levings MK, Steiner TS.
    Cell Mol Gastroenterol Hepatol; 2020 Feb 05; 9(3):485-506. PubMed ID: 31790809
    [Abstract] [Full Text] [Related]

  • 35. Fungal microbiota dysbiosis in IBD.
    Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L.
    Gut; 2017 Jun 05; 66(6):1039-1048. PubMed ID: 26843508
    [Abstract] [Full Text] [Related]

  • 36. Microbiota and IBD: Current knowledge and future perspectives.
    Foppa C, Rizkala T, Repici A, Hassan C, Spinelli A.
    Dig Liver Dis; 2024 Jun 05; 56(6):911-922. PubMed ID: 38008696
    [Abstract] [Full Text] [Related]

  • 37. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA, Lamb CA, Berry SH, Walker AW, Mansfield J, Parkes M, Simpkins R, Tremelling M, Nutland S, UK IBD Genetics Consortium, Parkhill J, Probert C, Hold GL, Lees CW.
    Inflamm Bowel Dis; 2018 Feb 15; 24(3):583-592. PubMed ID: 29462388
    [Abstract] [Full Text] [Related]

  • 38. Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
    Berbisá MÁF, Nielsen KR, Ingham AC, Midjord J, Hammer T, Patursson P, Vest NMO, Gregersen NO, Burisch J, Vang A.
    Inflamm Bowel Dis; 2022 Jul 01; 28(7):1081-1089. PubMed ID: 35138361
    [Abstract] [Full Text] [Related]

  • 39. A microbial signature for Crohn's disease.
    Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C.
    Gut; 2017 May 01; 66(5):813-822. PubMed ID: 28179361
    [Abstract] [Full Text] [Related]

  • 40. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
    Cardoneanu A, Mihai C, Rezus E, Burlui A, Popa I, Cijevschi Prelipcean C.
    J Gastrointestin Liver Dis; 2021 Mar 12; 30(1):46-54. PubMed ID: 33548121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.